General Information of the Compound
Compound ID
CP0185378
Compound Name
N-[(4-tert-butylphenyl)methyl]-1,5-dimethyl-4,4-dioxopyrazolo[4,3-c][2,1]benzothiazin-8-amine
    Show/Hide
Synonyms
1BR
4i4f
BDBM50430287
GTPL7864
PMID23414845C30
    Show/Hide
Structure
Formula
C22H26N4O2S
Molecular Weight
410.543
Canonical SMILES
CN1c2ccc(NCc3ccc(cc3)C(C)(C)C)cc2-c2c(cnn2C)S1(=O)=O
    Show/Hide
InChI
InChI=1S/C22H26N4O2S/c1-22(2,3)16-8-6-15(7-9-16)13-23-17-10-11-19-18(12-17)21-20(14-24-25(21)4)29(27,28)26(19)5/h6-12,14,23H,13H2,1-5H3
    Show/Hide
InChIKey
AVFJKWOKOZKXRX-UHFFFAOYSA-N
Physicochemical Property
logP
4.1352
Rotatable Bonds
3
Heavy Atom Count
29
Polar Areas
67.23
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 70698427
SID: 163593576
ChEMBL ID
CHEMBL2333444
Clinical Information about the Compound
Drug 1 ( PMID23414845C30 )
Drug Name PMID23414845C30
Target(s)
Focal adhesion kinase 1 (FAK)
Inhibitor